Dr. Gattu is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
55 Fruit St
Boston, MA 02114Phone+1 617-724-2718
Education & Training
Griffin HospitalResidency, Internal Medicine, 2016 - 2019
Gandhi Medical CollegeClass of 2003
Yale-New Haven HospitalPost-Doctoral Fellowship, Endocrinology Gastroenterology- Yale UniversityCell Biology, Masters
Certifications & Licensure
MA State Medical License 2019 - 2025
CT State Medical License 2016 - 2019- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Endocrinology, Diabetes and Metabolism
Publications & Presentations
PubMed
- 5 citationsLeucine-973 is a crucial residue differentiating insulin and IGF-1 receptor signaling.Hirofumi Nagao, Weikang Cai, Bruna B Brandão, Nicolai J Wewer Albrechtsen, Martin Steger
The Journal of Clinical Investigation. 2023-02-15 - The anabolic applications of androgens in older adults with functional limitations.Arijeet K Gattu, Anna L Goldman, Ezgi Caliskan Guzelce, Francesca Galbiati, Shalender Bhasin
Reviews in Endocrine & Metabolic Disorders. 2022-12-01 - 6 citationsPEPCK1 Antisense Oligonucleotide Prevents Adiposity and Impairs Hepatic Glycogen Synthesis in High-Fat Male Fed Rats.Sara A. Beddow, Arijeet K. Gattu, Daniel F. Vatner, Lauren Paolella, Abdulelah Alqarzaee
Endocrinology. 2019-01-01
Journal Articles
- PEPCK1 Antisense Oligonucleotide Prevents Adiposity and Impairs Hepatic Glycogen Synthesis in High-Fat Male Fed RatsArijeet K Gattu, Varman T Samuel, Violeta Popov, Daniel F Vatner, Gary Cline, Endocrinology
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
